Boston Scientific (BSX) Expands Urology Portfolio with Valencia Deal, Analysts Emphasize Organic Growth
“Boston Scientific’s acquisition of Valencia Technologies strengthens its urology segment with innovative neuromodulation tech for overactive bladder, while analysts spotlight …